Myomo vs Sanuwave Health
Myomo and Sanuwave Health are similar in size: $40.9m and $44.1m of revenue in their latest fiscal years. Sanuwave Health grew faster (35.0% against 25.7%). Sanuwave Health kept more of each dollar of sales as profit: a net margin of 26.8% against -38.1%. Myomo carries less debt relative to equity (109.9% against 1372.3%).
| Latest fiscal year | MyomoMYO, 2025 | Sanuwave HealthSNWV, 2025 |
|---|---|---|
| Revenue | $40.9m | $44.1m |
| Revenue growth | 25.7% | 35.0% |
| Net income | −$15.6m | $11.8m |
| Operating margin | -35.2% | 11.2% |
| Net margin | -38.1% | 26.8% |
| Return on equity | -86.2% | — |
| Free cash flow | −$16.3m | $1.9m |
| Cash | $14.1m | $12.0m |
| Total debt | $12.5m | $22.2m |
| Debt to equity | 109.9% | 1372.3% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | 55 |
| Market value | $50.6m | $51.4m |
| Price vs our value range | — | — |
| Moat score | 33 (Weak) | 33 (Weak) |
| Insider trades, 12 months | 13 buys, 8 sales | 0 buys, 21 sales |